- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x GLC: alpha-D-glucopyranose(Non-covalent)
- 2 x IHU: N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA(Non-covalent)
IHU.2: 13 residues within 4Å:- Chain A: L.39, V.40, K.41, D.42, N.44, V.45
- Chain B: W.67, I.68, Q.71, Q.72, K.191, R.193, D.227
10 PLIP interactions:5 interactions with chain B, 5 interactions with chain A- Hydrophobic interactions: B:Q.72, A:V.40, A:V.45
- Water bridges: B:R.193, B:R.193
- pi-Stacking: B:W.67
- Halogen bonds: B:W.67
- Hydrogen bonds: A:V.40, A:D.42, A:N.44
IHU.5: 13 residues within 4Å:- Chain A: W.67, I.68, Q.71, Q.72, K.191, R.193, D.227
- Chain B: L.39, V.40, K.41, D.42, N.44, V.45
13 PLIP interactions:7 interactions with chain A, 6 interactions with chain B- Hydrophobic interactions: A:Q.72, A:Q.72, B:V.40, B:K.41, B:V.45
- Hydrogen bonds: A:Q.72, B:V.40, B:D.42, B:N.44
- Water bridges: A:R.193, A:R.193
- pi-Stacking: A:W.67
- Halogen bonds: A:W.67
- 2 x PLP: PYRIDOXAL-5'-PHOSPHATE(Covalent)
PLP.3: 15 residues within 4Å:- Chain A: Y.90, G.134, G.135, W.491, V.567, K.568, K.574, Y.648, R.649, V.650, A.653, G.675, T.676, G.677, K.680
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:Y.90, A:Y.648, A:K.680
- Hydrogen bonds: A:V.567, A:T.676, A:T.676, A:G.677
- Water bridges: A:K.568, A:N.678, A:N.678
- Salt bridges: A:K.568, A:K.574
PLP.6: 15 residues within 4Å:- Chain B: Y.90, G.134, G.135, W.491, V.567, K.568, K.574, Y.648, R.649, V.650, A.653, G.675, T.676, G.677, K.680
18 PLIP interactions:18 interactions with chain B- Hydrophobic interactions: B:Y.90, B:Y.648, B:K.680
- Hydrogen bonds: B:V.567, B:T.676, B:T.676, B:T.676, B:G.677
- Water bridges: B:Y.90, B:G.135, B:K.568, B:K.574, B:K.574, B:K.574, B:N.678, B:N.678
- Salt bridges: B:K.568, B:K.574
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Klabunde, T. et al., Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. J.Med.Chem. (2005)
- Release Date
- 2006-08-25
- Peptides
- Glycogen phosphorylase, liver form: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x GLC: alpha-D-glucopyranose(Non-covalent)
- 2 x IHU: N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA(Non-covalent)
- 2 x PLP: PYRIDOXAL-5'-PHOSPHATE(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Klabunde, T. et al., Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. J.Med.Chem. (2005)
- Release Date
- 2006-08-25
- Peptides
- Glycogen phosphorylase, liver form: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B